Share the post "Aarti Pharmalabs announced Financial Results Q1 2024"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 21.19 % in the past year, substantial increase in net sales/revenue by 9.83 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 361.67 %. Marginal increase in other income during this quarter, up by 8.89%.
- Profit over the Year and quarter: Significant improvement in profitability for Aarti Pharmalabs Limited. Notable increase of 17.76 % in net profit Year to Year, Aarti Pharmalabs Limited’s profitability dropped by -15.02 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 17.69 % Year to Year. EPS decreased by -15 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 458.36 Cr | Rs. 505.767 Cr | Rs. 555.493 Cr | + 9.83 % | + 21.19 % |
| Expenses | Rs. 373.49 Cr | Rs. 388.25 Cr | Rs. 459.04 Cr | + 18.23 % | + 22.91 % |
| Operating Profit | Rs. 84.87 Cr | Rs. 117.52 Cr | Rs. 96.45 Cr | -17.93 % | + 13.64 % |
| OPM % | 18.52 % | 23.24 % | 17.36 % | -5.88 % | -1.16 % |
| Other Income | Rs. 0.48 Cr | Rs. 2.035 Cr | Rs. 2.216 Cr | + 8.89 % | + 361.67 % |
| Interest | Rs. 4.17 Cr | Rs. 4.68 Cr | Rs. 4.83 Cr | + 3.21 % | + 15.83 % |
| Depreciation | Rs. 17.2 Cr | Rs. 19.12 Cr | Rs. 20.17 Cr | + 5.49 % | + 17.27 % |
| Profit before tax | Rs. 63.98 Cr | Rs. 95.76 Cr | Rs. 73.67 Cr | -23.07 % | + 15.15 % |
| Tax % | 26.4 % | 31.85 % | 24.73 % | -7.12 % | -1.67 % |
| Net Profit | Rs. 47.09 Cr | Rs. 65.25 Cr | Rs. 55.45 Cr | -15.02 % | + 17.75 % |
| EPS in Rs | Rs. 5.2 | Rs. 7.2 | Rs. 6.12 | -15 % | + 17.69 % |
Today, we’re looking at Aarti Pharmalabs Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 21.19 %. However, it did see a marginal increase of 9.83 % from the previous quarter. Expenses ticked up slightly by 18.23 % quarter-on-quarter, aligning with the annual rise of 22.91 %. Operating profit, while up 13.64 % compared to last year, faced a quarter-on-quarter dip of -17.93 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -1.16 %, but a shrinkage of -5.88 % sequentially. Other income rose by 8.89 % compared to the last quarter, despite an annual growth of 361.67 %. Interest expenses surged remarkably by 3.21 % from the previous quarter, yet the year-over-year increase remains at a moderate 15.83 %. Depreciation costs climbed by 5.49 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 17.27 %. Profit before tax grew annually by 15.15 % but saw a reduction from the preceding quarter by -23.07 %.
Tax expenses as a percentage of profits decreased slightly by -1.67 % compared to last year, with a more notable quarter-on-quarter decrease of -7.12 %. Net profit rose by 17.75 % year-on-year but witnessed a -15.02 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 17.69 % but a quarterly fall of -15 %. In summary, Aarti Pharmalabs Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 458.36 Cr | Rs. 505.767 Cr | Rs. 555.493 Cr | + 9.83 % | + 21.19 % |
| Expenses | Rs. 373.49 Cr | Rs. 388.25 Cr | Rs. 459.04 Cr | + 18.23 % | + 22.91 % |
| Operating Profit | Rs. 84.87 Cr | Rs. 117.52 Cr | Rs. 96.45 Cr | -17.93 % | + 13.64 % |
| Net Profit | Rs. 47.09 Cr | Rs. 65.25 Cr | Rs. 55.45 Cr | -15.02 % | + 17.75 % |
| EPS in Rs | Rs. 5.2 | Rs. 7.2 | Rs. 6.12 | -15 % | + 17.69 % |
In reviewing Aarti Pharmalabs Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 21.19 % year-on-year growth, however, there was a minor increase of 9.83 % from the previous quarter. Expenses rose by 22.91 % compared to the previous year, with a 18.23 % increase quarter-on-quarter. Operating Profit surged by 13.64 % annually, and saw a -17.93 % decrease from the last quarter.
Net Profit showed yearly increase of 17.75 %, and experienced a -15.02 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 17.69 % annually, however dipped by -15 % compared to the last quarter. In essence, while Aarti Pharmalabs Limited exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”Aarti Pharmalabs “]
